Tissue-specific immunopathology in fatal COVID-19
…, X Dong, AM Anderson, VL Campbell… - American journal of …, 2021 - atsjournals.org
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality,
suggesting that immune responses have a causal role in death. Whether this deleterious …
suggesting that immune responses have a causal role in death. Whether this deleterious …
Bond-selective control of a heterogeneously catalyzed reaction
DR Killelea, VL Campbell, NS Shuman, AL Utz - Science, 2008 - science.org
Energy redistribution, including the many phonon-assisted and electronically assisted
energy-exchange processes at a gas-metal interface, can hamper vibrationally mediated …
energy-exchange processes at a gas-metal interface, can hamper vibrationally mediated …
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
…, VL Campbell, CL McClurkan, L Jing… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND SARS-CoV-2–specific antibodies may protect from reinfection and disease,
providing rationale for administration of plasma containing SARS-CoV-2–neutralizing …
providing rationale for administration of plasma containing SARS-CoV-2–neutralizing …
Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells
…, P Agarwal, VL Campbell, L Hopcroft… - Blood, The Journal …, 2016 - ashpublications.org
Abstract Treatment of chronic myelogenous leukemia (CML) with BCR-ABL tyrosine kinase
inhibitors (TKI) fails to eliminate leukemia stem cells (LSC). Patients remain at risk for relapse…
inhibitors (TKI) fails to eliminate leukemia stem cells (LSC). Patients remain at risk for relapse…
[PDF][PDF] Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies
…, W West, T Knurowski, K Frese, K Clegg, VL Campbell… - Cancer Cell, 2023 - cell.com
CCS1477 (inobrodib) is a potent, selective EP300/CBP bromodomain inhibitor which induces
cell-cycle arrest and differentiation in hematologic malignancy model systems. In myeloid …
cell-cycle arrest and differentiation in hematologic malignancy model systems. In myeloid …
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
…, R Kinstrie, A Tarafdar, H Morrison, VL Campbell… - Scientific reports, 2016 - nature.com
Targeting the Hedgehog (Hh) pathway represents a potential leukaemia stem cell (LSC)-directed
therapy which may compliment tyrosine kinase inhibitors (TKIs) to eradicate LSC in …
therapy which may compliment tyrosine kinase inhibitors (TKIs) to eradicate LSC in …
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy
…, ML Huang, VL Campbell… - Blood …, 2023 - ashpublications.org
COI notes: JAH received consulting fees or honoraria from Gilead Sciences, Amplyx, Allovir,
Allogene therapeutics, CRISPR therapeutics, CSL Behring, OptumHealth, Octapharma, and …
Allogene therapeutics, CRISPR therapeutics, CSL Behring, OptumHealth, Octapharma, and …
[HTML][HTML] T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components
SARS-CoV-2 provokes a robust T cell response. Peptide-based studies exclude antigen
processing and presentation biology, which may influence T cell detection studies. To focus on …
processing and presentation biology, which may influence T cell detection studies. To focus on …
Viral shedding 1 year following first-episode genital HSV-1 infection
…, M Szpara, S Gunby, M Ott, L Jing, VL Campbell… - Jama, 2022 - jamanetwork.com
Importance Herpes simplex virus type 1 (HSV-1) is the leading cause of first-episode genital
herpes in many countries. Objective To inform counseling messages regarding genital HSV-…
herpes in many countries. Objective To inform counseling messages regarding genital HSV-…
Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
…, D Ibrani, IT Chow, KJ Laing, VL Campbell… - Cancer immunology …, 2019 - AACR
Although CD4 + T cells likely play key roles in antitumor immune responses, most immuno-oncology
studies have been limited to CD8 + T-cell responses due to multiple technical …
studies have been limited to CD8 + T-cell responses due to multiple technical …
